in cost variations. Furthermore, some consultants seemed to treat large numbers of patients while others treated only small numbers in the same department. At times the number of patients treated by a consultant was too small to obtain a useful average cost figure. The largest cost variations per inpatient day were in the departments of neurosurgery (£1C51 to £l1718), haematology (JO-69 to £18-99), and radiotherapy (CO-38 to £65 83). In the haematology and radiotherapy departments the highest cost prescribers seemed to be those that treated the largest numbers of patients. So the average costs per inpatient day of these specialties are relatively close to those of the highest cost consultant. Many patients travel quite large distances across regional and district boundaries to be treated in Addenbrooke's Hospital. It might be thought that these "migratory" patients were relatively seriously ill and, therefore, high cost cases. The study did not support this hypothesis, as average costs for each individual specialty did not differ according to the geographical origin of the patient. Table II shows expenditure by drug category. Most drugs prescribed in hospital cost less than 25p per patient per day and nearly all cost less than £1. The few remaining relatively expensive categories account for a disproportionately large part of total hospital expenditure on drugs. Expenditure on antibiotics in the haematology and neonatal intensive care departments and on diuretics in the nephrology department was over £1 per patient per day. The highest expenditure (113 30 and £22) was on cancer chemotherapy in the haematology and radiotherapy departments. Expenditure on this category of drugs accounted for over 75% of the total drug bill for these specialties. Subtracting the costs of cancer chemotherapy does not bring haematology in line with the costs of other departments, as this specialty also had higher than normal costs in other drug categories, notably analgesics, antibiotics, anticoagulants, and gastrointestinal drugs. A further range of drugs used by specialties was not priced, as they were available to the hospital free of charge for research purposes at the time of the study.
The total annual cost of drugs for each specialty in 1980 was estimated from these data (table III) . Radiotherapy and haematology accounted for over £400 000, or between a third and a half of the total drug bill of the hospital. This result could have important implications for the allocation of resources as most patients in these specialties were "migratory" patients from other health districts. In principle, forecasts of drug expenditure may also be made with these data by adjusting for changes in prices and work loads of departments. These would be useful for planning purposes, as hospital pharmaceutical budgets are frequently underestimated.
Discussion and conclusions
Hospital drug costing and budgeting is a relatively new area, but the procedures seem straightforward. A continuous monitor- ing procedure could well adopt a more efficient method than that used for this study as an adaptive sampling strategy could be used. Alternatively, there is now a range of minicomputers that will produce labels for prescriptions dispensed and, at the same time, store information on the nature and quantities of items dispensed. These are primarily intended for the retail pharmacy trade as aids to the efficient control of stocks in store. Facilities of this type could, with minor amendments, provide the total cost and a breakdown of items dispensed to individual specialties. In the year after this study pharmaceutical -expenditure declined by 10%, or ClOO 000 in Addenbrooke's Hospital. The -study cost the hospital CJ1 1 000.
